查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945385

2026年全球胰岛素输注装置市场报告

Insulin Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，胰岛素输注装置市场成长显着，预计将从2025年的190.7亿美元成长到2026年的206.1亿美元，复合年增长率为8.1%。过去几年的成长可归因于糖尿病盛行率的上升、糖尿病管理意识的提高、胰岛素治疗的普及、医疗保健服务的改善以及自行注射的增加。

预计未来几年，胰岛素输注装置市场将维持强劲成长，2030年市场规模将达到280.3亿美元，复合年增长率（CAGR）为8.0%。预测期内的成长可归因于以下因素：全球糖尿病盛行率不断上升、对便捷胰岛素给药方式的需求日益增长、对长期糖尿病管理的日益重视、新兴市场糖尿病护理服务覆盖范围的扩大以及居家医疗解决方案的普及。预测期内的主要趋势包括：胰岛素笔作为传统注射器的替代品得到更广泛的应用、对用于持续胰岛素输注的胰岛素帮浦的需求不断增长、对易于使用和便携式胰岛素装置的偏好日益增强、家庭糖尿病管理解决方案的扩展以及一次性及预填充胰岛素输注装置的使用量增加。

预计未来几年，糖尿病盛行率的不断上升将推动胰岛素输注装置市场的成长。糖尿病是一种慢性疾病，由于胰臟胰岛素分泌不足或人体无法有效利用胰岛素，导致血糖值升高。糖尿病患者人数的增加主要归因于缺乏运动、饮食不健康以及全球肥胖率上升等因素。胰岛素输注装置对于糖尿病管理至关重要，因为它们能够以可控的方式输注胰岛素，有效控制血糖值，预防併发症并促进健康。例如，根据总部位于比利时的非政府组织国际糖尿病联盟（IDF）统计，截至2024年，全球约有5.89亿20至79岁的成年人患有糖尿病。预计到2050年，这数字将达到8.53亿。糖尿病盛行率的不断上升正在推动胰岛素输注装置市场的扩张。

胰岛素输注设备市场的主要企业正致力于开发创新产品，例如能够实现持续或个人化胰岛素输注的胰岛素帮浦。胰岛素帮浦是可程式设计医疗设备，可透过皮下植入的导管持续或按需输注胰岛素。例如，2023年5月，总部位于美国的医疗科技公司Beta Bionics的iLet ACE胰岛素帮浦和iLet剂量决策软体获得了美国食品药物管理局（FDA）的核准。 iLet仿生胰臟系统专为6岁及以上第1型糖尿病患者设计，整合了两个设备以及一个相容的、已获FDA批准的整合式连续血糖监测仪（iCGM）。本系统采用自适应闭合迴路演算法，作为自动胰岛素输注（AID）系统运行，设定时仅需使用者的体重，无需其他胰岛素输注参数。与传统的胰岛素帮浦治疗不同，该系统无需手动调整设置，因此易于实施和管理。此外，iLet设备还具有餐前提醒功能，并透过将餐点分为小份、中份和大份，简化了餐前胰岛素的给药。该演算法会随着时间的推移学习并适应您个人的胰岛素需求。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球胰岛素输注装置市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
  • 主要趋势
    • 与传统注射器相比，胰岛素笔的使用率正在不断提高。
    • 对用于持续胰岛素输注的胰岛素帮浦的需求不断增长
    • 消费者越来越倾向选择操作简单、便携的胰岛素设备。
    • 拓展居家糖尿病管理解决方案
    • 一次性预填充胰岛素输注装置的使用日益增多

第五章 终端用户产业市场分析

  • 医院
  • 糖尿病诊所或中心
  • 居家医疗环境
  • 门诊治疗中心
  • 内分泌专科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球胰岛素输注装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球胰岛素输注装置市场规模、比较及成长率分析
  • 全球胰岛素输注装置市场表现：规模与成长，2020-2025年
  • 全球胰岛素输注装置市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 胰岛素注射器、胰岛素喷射注射器、笔针、可重覆使用胰岛素笔、抛弃式胰岛素笔
  • 按疾病指征
  • 类型 1，类型 2
  • 透过分销管道
  • 医院药局、零售药局、线上零售商、糖尿病诊所或中心
  • 依类型细分：胰岛素注射器
  • 标准胰岛素注射器，包括固定针长或可调节针长的胰岛素注射器
  • 依类型细分：胰岛素喷射注射器
  • 无针胰岛素喷射注射器，高压胰岛素喷射注射器
  • 按类型细分：注射笔针
  • 短笔针，长笔针
  • 依类型细分：可重复使用胰岛素笔
  • 可重复使用的笔，附有可更换笔芯，可填充胰岛素笔
  • 按类型细分：抛弃式胰岛素笔
  • 抛弃式胰岛素笔，预填充式抛弃式胰岛素笔

第十章 区域与国家分析

  • 全球胰岛素输注装置市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球胰岛素输注装置市场：国家、实际结果与预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 胰岛素输注装置市场：竞争格局及市占率（2024年）
  • 胰岛素输注装置市场：公司估值矩阵
  • 胰岛素输注装置市场：公司概况
    • Novo Nordisk A/S
    • Medtronic Plc
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • Ypsomed Holding AG

第37章：其他领先和创新企业

  • Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年胰岛素输注装置市场：提供新机会的国家
  • 2030年胰岛素输注装置市场：充满新机会的细分市场
  • 2030年胰岛素输注装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIDDE01_G26Q1

Insulin delivery devices are medical tools designed to administer insulin to individuals with diabetes. These devices are essential for managing blood glucose levels in people who are unable to produce sufficient insulin naturally. They help control blood sugar levels effectively, offering flexibility and convenience in insulin administration.

The primary types of insulin delivery devices include insulin syringes, insulin jet injectors, pen needles, reusable insulin pens, disposable insulin pens, insulin pumps, external or tethered pumps, and patch pumps. Insulin syringes, in particular, are designed for the subcutaneous injection of insulin, featuring fine, short needles and clearly marked dosage indicators to ensure precise hormone delivery. These devices are used for both type 1 and type 2 diabetes and are available through various channels, including hospital pharmacies, retail pharmacies, online sales, and diabetes clinics or centers.

Tariffs have introduced cost pressures in the insulin delivery devices market by increasing duties on imported medical-grade plastics, electronic components, and precision manufacturing equipment. These impacts have raised production and distribution costs, particularly affecting insulin pumps, smart devices, and pen-based delivery systems, with north america and asia-pacific regions experiencing higher exposure due to globalized supply chains. Healthcare providers and pharmacies have faced pricing pressures that influence device affordability and adoption. On the positive side, tariffs have encouraged local manufacturing, regional sourcing of components, and supply chain diversification, supporting long-term production resilience.

The insulin delivery devices market research report is one of a series of new reports from The Business Research Company that provides insulin delivery devices market statistics, including insulin delivery devices industry global market size, regional shares, competitors with a insulin delivery devices market share, detailed insulin delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the insulin delivery devices industry. This insulin delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The insulin delivery devices market size has grown strongly in recent years. It will grow from $19.07 billion in 2025 to $20.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of diabetes, growing awareness of diabetes management, increased availability of insulin therapies, expansion of healthcare access, rising adoption of self-injection practices.

The insulin delivery devices market size is expected to see strong growth in the next few years. It will grow to $28.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing global diabetic population, rising demand for convenient insulin delivery methods, growing focus on long-term diabetes management, expanding access to diabetes care in emerging markets, increasing adoption of home healthcare solutions. Major trends in the forecast period include rising adoption of insulin pens over traditional syringes, growing demand for insulin pumps for continuous insulin delivery, increasing preference for user-friendly and portable insulin devices, expansion of home-based diabetes management solutions, growing use of disposable and pre-filled insulin delivery devices.

The increasing prevalence of diabetes is expected to drive the growth of the insulin delivery device market in the coming years. Diabetes is a chronic condition characterized by elevated blood sugar levels due to either insufficient insulin production by the pancreas or the body's inability to effectively use insulin. The rise in diabetes cases is largely attributed to factors such as sedentary lifestyles, poor diets, and increasing obesity rates worldwide. Insulin delivery devices are essential for managing diabetes, as they allow individuals to control their blood sugar levels effectively by administering insulin in a controlled and convenient manner, thus preventing complications and promoting overall health. For example, according to the International Diabetes Federation, a Belgium-based non-governmental organization, in 2024, approximately 589 million adults aged 20-79 were living with diabetes worldwide. This figure is projected to rise to 853 million by 2050. This growing prevalence of diabetes is fueling the expansion of the insulin delivery device market.

Leading companies in the insulin delivery device market are focusing on developing innovative products, such as insulin pumps, which provide continuous or customizable insulin delivery. Insulin pumps are programmable medical devices that deliver insulin continuously or on demand through a catheter placed under the skin. For instance, in May 2023, Beta Bionics, a U.S.-based medical technology company, received approval from the U.S. Food and Drug Administration for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system, designed for individuals aged six and older with type 1 diabetes, integrates two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system operates using an automated insulin dosing (AID) system driven by an adaptive closed-loop algorithm, which only requires the user's body weight for setup and eliminates the need for additional insulin dosing parameters. Unlike traditional pump therapy, this system requires no manual adjustment of settings, making it easier to initiate and manage. Additionally, the iLet device introduces a meal announcement feature that simplifies mealtime insulin dosing by categorizing meals as small, medium, or large, with the algorithm learning and adapting to individual insulin needs over time.

In September 2023, Abbott, a U.S.-based healthcare company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by expanding its renowned FreeStyle Libre portfolio of continuous glucose monitoring technology. The move aligns with Abbott's strategy to advance connected solutions, aiming to personalize and refine diabetes management. Bigfoot Biomedical is a U.S.-based manufacturer of insulin delivery devices.

Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the insulin delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The insulin delivery devices market consists of sales of insulin infusion sets, insulin reservoirs, insulin pump accessories, and insulin cartridges. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses insulin delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for insulin delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Insulin Syringes; Insulin Jet Injectors; Pen Needles; Reusable Insulin Pens; Disposable Insulin Pens
  • 2) By Disease Indication: Type 1; Type 2
  • 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics Or Centers
  • Subsegments:
  • 1) By Insulin Syringes: Standard Insulin Syringes; Insulin Syringes With Fixed Or Adjustable Needle Length
  • 2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors; High-Pressure Insulin Jet Injectors
  • 3) By Pen Needles: Short Pen Needles; Long Pen Needles
  • 4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges; Refillable Insulin Pens
  • 5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens; Pre-Filled Disposable Insulin Pens
  • Companies Mentioned: Novo Nordisk A/S; Medtronic Plc; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Becton Dickinson and Company; Sanofi SA; Eli Lilly and Company; Abbott Laboratories; EOFlow Co. Ltd.; Beta Bionics Inc.; Bigfoot Biomedical Inc.; CeQur Corporation; Emperra GmbH; Debiotech SA; AMF Medical SA; Aerami Therapeutics Inc.; Andain Inc.; Apex Medical Devices; Animas Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Insulin Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Insulin Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Insulin Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Insulin Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Insulin Pens Over Traditional Syringes
    • 4.2.2 Growing Demand For Insulin Pumps For Continuous Insulin Delivery
    • 4.2.3 Increasing Preference For User-Friendly And Portable Insulin Devices
    • 4.2.4 Expansion Of Home-Based Diabetes Management Solutions
    • 4.2.5 Growing Use Of Disposable And Pre-Filled Insulin Delivery Devices

5. Insulin Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diabetes Clinics Or Centers
  • 5.3 Home Care Settings
  • 5.4 Ambulatory Care Centers
  • 5.5 Specialty Endocrinology Clinics

6. Insulin Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Insulin Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Insulin Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Insulin Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Insulin Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Insulin Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Insulin Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Insulin Delivery Devices Market Segmentation

  • 9.1. Global Insulin Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens
  • 9.2. Global Insulin Delivery Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Type 1, Type 2
  • 9.3. Global Insulin Delivery Devices Market, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
  • 9.4. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Syringes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
  • 9.5. Global Insulin Delivery Devices Market, Sub-Segmentation Of Insulin Jet Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
  • 9.6. Global Insulin Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Short Pen Needles, Long Pen Needles
  • 9.7. Global Insulin Delivery Devices Market, Sub-Segmentation Of Reusable Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
  • 9.8. Global Insulin Delivery Devices Market, Sub-Segmentation Of Disposable Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

10. Insulin Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Insulin Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Insulin Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Insulin Delivery Devices Market

  • 11.1. Asia-Pacific Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Insulin Delivery Devices Market

  • 12.1. China Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Insulin Delivery Devices Market

  • 13.1. India Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Insulin Delivery Devices Market

  • 14.1. Japan Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Insulin Delivery Devices Market

  • 15.1. Australia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Insulin Delivery Devices Market

  • 16.1. Indonesia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Insulin Delivery Devices Market

  • 17.1. South Korea Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Insulin Delivery Devices Market

  • 18.1. Taiwan Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Insulin Delivery Devices Market

  • 19.1. South East Asia Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Insulin Delivery Devices Market

  • 20.1. Western Europe Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Insulin Delivery Devices Market

  • 21.1. UK Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Insulin Delivery Devices Market

  • 22.1. Germany Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Insulin Delivery Devices Market

  • 23.1. France Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Insulin Delivery Devices Market

  • 24.1. Italy Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Insulin Delivery Devices Market

  • 25.1. Spain Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Insulin Delivery Devices Market

  • 26.1. Eastern Europe Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Insulin Delivery Devices Market

  • 27.1. Russia Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Insulin Delivery Devices Market

  • 28.1. North America Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Insulin Delivery Devices Market

  • 29.1. USA Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Insulin Delivery Devices Market

  • 30.1. Canada Insulin Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Insulin Delivery Devices Market

  • 31.1. South America Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Insulin Delivery Devices Market

  • 32.1. Brazil Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Insulin Delivery Devices Market

  • 33.1. Middle East Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Insulin Delivery Devices Market

  • 34.1. Africa Insulin Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Insulin Delivery Devices Market, Segmentation By Type, Segmentation By Disease Indication, Segmentation By Distribution Channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Insulin Delivery Devices Market Regulatory and Investment Landscape

36. Insulin Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Insulin Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Insulin Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Insulin Delivery Devices Market Company Profiles
    • 36.3.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tandem Diabetes Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

37. Insulin Delivery Devices Market Other Major And Innovative Companies

  • Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation

38. Global Insulin Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Insulin Delivery Devices Market

40. Insulin Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Insulin Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Insulin Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Insulin Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer